LBF22506SC01: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 8: | Line 8: | ||
|SysName=4, 7, 10, 13, 16-Docosapentaenoic acid | |SysName=4, 7, 10, 13, 16-Docosapentaenoic acid | ||
|Common Name=&&4, 7, 10, 13, 16-Docosapentaenoic acid&& | |Common Name=&&4, 7, 10, 13, 16-Docosapentaenoic acid&& | ||
|Solubility=soluble in chloroform, heptane and | |Solubility=soluble in chloroform, heptane and methyl alcohol.<!--0269--> | ||
|Source=Brain phosphatides. | |Source=Brain phosphatides. | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism=The synthesis of 4,7,10,13,16-22:5 occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12-18:2 --> 6,9,12-18:3 --> 8,11,14-20:3 --> 5,8,11,14-20:4 --> 7,10,13,16-22:4 --> 9,12,15,18-24:4 --> 6,9,12,15,18-24:5 --> 4,7,10,13,16-22:5. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes. | |Metabolism=The synthesis of 4,7,10,13,16-22:5 occurs via the following reaction sequence [[Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471|{{RelationTable/GetFirstAuthor|Reference:Sprecher_H:Luthria_DL:Mohammed_BS:Baykousheva_SP:,J. Lipid. Res.,1995,36,2471}}]]: 9,12-18:2 --> 6,9,12-18:3 --> 8,11,14-20:3 --> 5,8,11,14-20:4 --> 7,10,13,16-22:4 --> 9,12,15,18-24:4 --> 6,9,12,15,18-24:5 --> 4,7,10,13,16-22:5. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes. | ||
|Symbol=C22:5n-6 / C22: | |Symbol=C22:5n-6 / C22:5 omega 6 | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Latest revision as of 17:14, 14 May 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA0221 |
| LipidMaps | LMFA01030182 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF22506SC01 |
| 4, 7, 10, 13, 16-Docosapentaenoic acid | |
|---|---|
| |
| Structural Information | |
| 4, 7, 10, 13, 16-Docosapentaenoic acid | |
| |
| C22:5n-6 / C22:5 omega 6 | |
| Formula | C22H34O2 |
| Exact Mass | 330.255880332 |
| Average Mass | 330.50416000000007 |
| SMILES | C(CCC(O)=O)=CCC=CCC=CCC=CCC=CCCCCC |
| Physicochemical Information | |
| soluble in chloroform, heptane and methyl alcohol. | |
| Brain phosphatides. | |
| The synthesis of 4,7,10,13,16-22:5 occurs via the following reaction sequence Sprecher_H et al.: 9,12-18:2 --> 6,9,12-18:3 --> 8,11,14-20:3 --> 5,8,11,14-20:4 --> 7,10,13,16-22:4 --> 9,12,15,18-24:4 --> 6,9,12,15,18-24:5 --> 4,7,10,13,16-22:5. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
